AR

Active Director Director DIN 09393346
DIN 09393346 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Alka Rani

Data last updated:

Alka Rani is a Director at Biota Remedies Private Limited (since 2021). The company operates in Chemicals. Biota Remedies Private Limited reported revenue of ₹51,136 (FY 2025).

DIN 09393346
Primary Designation Director
Industry Chemicals
First Appointment 10 Nov 2021
Oldest Company Age 5 yrs
Largest company Biota Remedies Private Limited · ₹51,136 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biota Remedies Private Limited U24230UP2021PTC155169
Director10 Nov 20212021₹51,136 (FY 2025)Active

Board colleagues of Alka Rani

Directorship timeline

Open interactive timeline →
Biota Remedies Private Limited
Premium access

Shareholding and investment profile for Alka Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Alka Rani

Alka Rani currently holds 1 directorship: Biota Remedies Private Limited (Director, since 10 Nov 2021, revenue ₹51,136 (FY 2025)).

Alka Rani was first appointed on 10 Nov 2021 as Director at Biota Remedies Private Limited.

The current boards of Alka Rani's companies include Avantika Singh (Biota Remedies Private Limited), Rajni Bala (Biota Remedies Private Limited), Vaijayanti Machhindr Sarbande (Biota Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available